base128

BASE•128

BASE•128 è una soluzione pronta all’uso per la decontaminazione di vari tessuti umani destinati al trapianto (pelle, membrana amniotica, tessuti cardiovascolari, tessuti venosi, tessuti ossei) in differenti condizioni di tempo e temperatura.

La miscela di quattro antibiotici (vancomicina, gentamicina, cefotaxime e amfotericina B deossicolato) è attiva contro i contaminanti riscontrati con maggiore frequenza nelle banche dei tessuti (batteri Gram+ e Gram-, lieviti e muffe).

La soluzione di decontaminazione BASE•128 può essere usata anche per il trasporto del tessuto alla banca, subito dopo prelievo, o durante la sua dissezione.

BAS 005-00

BASE•128 - 250 ml

BAS 006-00

BASE•128 - 500 ml

CE Certificate

Certificato CE / CE certificate (ITA+ENG)

1. Effects of temperature on decontamination efficacy of BASE.128 by in vitro Time-Kill studies.

2. Fate of antibiotics after the tissue decontamination phase: Study on pig heart valves.

3. Effects of tissue, time and temperature on the decontamination efficacy of BASE.128.

4. Fate of antibiotics after tissue decontamination. Study on heart valves, pericardium, bone and skin.

5. Comparison among the medical devices BASE.128, BASE, CRYO.ON and the solutions currently used in two Italian cardiovascular tissue banks.

6. Elimination of antibiotic carry-over from tissues decontaminated with BASE.128.

7. Validation of standardized industrial antibiotic cocktails.

8. Optimization of cardiovascular tissue decontamination and rinsing with BASE.128 and BASE.

9. Skin decontamination and impact of antibiotic residues on microbiological tests.

10. Time-Kill studies of BASE.128 against S. Epidermidis II, S. Capitis and P. Acnes isolated from donor skin.

11. Establishment of a rinsing procedure to eliminate antibiotic and glycerol residues from cryopreserved skin decontaminated with BASE.128.

12. Impact of antibiotic residues on microbiological analysis: implication of tissue banking.

13. Evaluation of different microbiological testing methods in tissue banking.

14. A suitable and efficient procedure for the removal of decontaminating antibiotics from tissue allografts.

15. Validation of a device for elimination of antibiotics from liquid samples undergoing microbiological analysis.

16. Validation of “ResEP tube” system for microbiological analysis with removal of antibiotic residues.

17. Residual antibiotics in decontaminated human cardiovascular tissues intended for transplantation and risk of falsely negative microbiological analyses.

18. Decontamination of umbilical cord tissue with BASE.128, time-kill studies.

19. Decontamination of Human Larynx with medical device BASE.128.

Categoria:

©Copyright 2017 AL.CHI.MI.A. SRL - - Viale Austria 14 - 35020 - Ponte San Nicolò - PD - Italia - Partita IVA IT-00063370282 - Capitale Sociale Euro 123.760,00 IE

Log in with your credentials

Forgot your details?